IL10 and COVID-19: Interestingly, recent improvements in the pathophysiologic understanding of COVID-19 revealed that the severity of COVID-19 is strongly associated with cytokine release syndrome (CRS), which is characterized by elevated tumor necrosis factor (TNF-α), interleukin (IL)-6, IL-2, IL-7, and IL-10.